review

Open Access
Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand Therapy in Prostate Cancer
GAKU YAMAMICHI, TAIGO KATO, TADASHI WATABE, KOJI HATANO, MOTOHIDE UEMURA and NORIO NONOMURA

Anticancer Research March 2024, 44 (3) 879-888; DOI: https://doi.org/10.21873/anticanres.16881
Open Access
Efficacy and Safety of Anti-angiogenic Agents for Cancer Patients With Proteinuria or a History of Proteinuria: A Systematic Review
TAIGO KATO, SHIMON KURASAWA, KENTARO TAKEZAWA, YUTAKA FUJIWARA, YOSHINARI YASUDA and YUICHI ANDO

Anticancer Research March 2024, 44 (3) 889-894; DOI: https://doi.org/10.21873/anticanres.16882
Open Access
Integration of the Molecular Classification of Endometrial Carcinoma to Select Patients for Fertility Sparing Strategies
MOHAMED AMINE BANI, AMANDINE MAULARD, PHILIPPE MORICE, CYRUS CHARGARI and CATHERINE GENESTIE

Anticancer Research February 2024, 44 (2) 445-452; DOI: https://doi.org/10.21873/anticanres.16832
Open Access
Intraventricular Cerebral Metastases: A Comprehensive Systematic Review
GIANLUCA SCALIA, MANIKON PULLAY SILVEN, ROBERTA COSTANZO, MASSIMILIANO PORZIO, ROSARIO MAUGERI, DOMENICO GERARDO IACOPINO, GIOVANNI FEDERICO NICOLETTI and GIUSEPPE EMMANUELE UMANA

Anticancer Research February 2024, 44 (2) 453-462; DOI: https://doi.org/10.21873/anticanres.16833
Open Access
Biparametric MRI for Local Staging of Prostate Cancer: Current Status and Future Applications
LUCIO DELL’ATTI

Anticancer Research February 2024, 44 (2) 463-470; DOI: https://doi.org/10.21873/anticanres.16834
Open Access
An Overview of Introductory and Advanced Survival Analysis Methods in Clinical Applications: Where Have we Come so far?
GEORGIOS BEIS, AGGELOS ILIOPOULOS and IOANNIS PAPASOTIRIOU

Anticancer Research February 2024, 44 (2) 471-487; DOI: https://doi.org/10.21873/anticanres.16835
Open Access
Proteinase-activated Receptor 2: Springboard of Tumors
DAVID VETVICKA, PETR SUHAJ, TOMAS OLEJAR, LADISLAV SIVAK, JIRI BENES and PAVLA POUCKOVA

Anticancer Research January 2024, 44 (1) 1-12; DOI: https://doi.org/10.21873/anticanres.16782
Open Access
Suppression of Kynurenine 3-Monooxygenase as a Treatment for Triple-negative Breast Carcinoma
LAURA A. SORDILLO and PETER P. SORDILLO

Anticancer Research December 2023, 43 (12) 5275-5282; DOI: https://doi.org/10.21873/anticanres.16731
Open Access
Mechanism of CDK4/6 Inhibitor Resistance in Hormone Receptor-positive Breast Cancer and Alternative Treatment Strategies
CHUN-MING CHANG and HO YIN PEKKLE LAM

Anticancer Research December 2023, 43 (12) 5283-5298; DOI: https://doi.org/10.21873/anticanres.16732
Open Access
Renal Cell Cancer – Insights in Drug Resistance Mechanisms
HALIMA AWEYS, DEISHA LEWIS, MATIN SHERIFF, RUKHSHANA DINA RABBANI, PATRICIA LAPITAN, ELISABET SANCHEZ, VASILEIOS PAPADOPOULOS, ARUNI GHOSE and STERGIOS BOUSSIOS

Anticancer Research November 2023, 43 (11) 4781-4792; DOI: https://doi.org/10.21873/anticanres.16675

Main menu

User menu

Search

review

Pages